Literature DB >> 19427003

Mouse models of Fanconi anemia.

Kalindi Parmar1, Alan D'Andrea, Laura J Niedernhofer.   

Abstract

Fanconi anemia is a rare inherited disease characterized by congenital anomalies, growth retardation, aplastic anemia and an increased risk of acute myeloid leukemia and squamous cell carcinomas. The disease is caused by mutation in genes encoding proteins required for the Fanconi anemia pathway, a response mechanism to replicative stress, including that caused by genotoxins that cause DNA interstrand crosslinks. Defects in the Fanconi anemia pathway lead to genomic instability and apoptosis of proliferating cells. To date, 13 complementation groups of Fanconi anemia were identified. Five of these genes have been deleted or mutated in the mouse, as well as a sixth key regulatory gene, to create mouse models of Fanconi anemia. This review summarizes the phenotype of each of the Fanconi anemia mouse models and highlights how genetic and interventional studies using the strains have yielded novel insight into therapeutic strategies for Fanconi anemia and into how the Fanconi anemia pathway protects against genomic instability.

Entities:  

Mesh:

Year:  2009        PMID: 19427003      PMCID: PMC2778466          DOI: 10.1016/j.mrfmmm.2009.03.015

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  91 in total

1.  Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice.

Authors:  Yue Si; Samantha Ciccone; Feng-Chun Yang; Jin Yuan; Daisy Zeng; Shi Chen; Henri J van de Vrugt; John Critser; Fre Arwert; Laura S Haneline; D Wade Clapp
Journal:  Blood       Date:  2006-08-31       Impact factor: 22.113

2.  Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence.

Authors:  Xiaoling Zhang; Daniel P Sejas; Yuhui Qiu; David A Williams; Qishen Pang
Journal:  J Cell Sci       Date:  2007-04-03       Impact factor: 5.285

3.  Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fancc-deficient mice.

Authors:  Daniel P Sejas; Reena Rani; Yuhui Qiu; Xiaoling Zhang; Sara R Fagerlie; Hiroyasu Nakano; David A Williams; Qishen Pang
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

4.  CXCR4 induction in hematopoietic progenitor cells from Fanca(-/-), -c(-/-), and -d2(-/-) mice.

Authors:  Amy M Skinner; S Lee O'Neill; Markus Grompe; Peter Kurre
Journal:  Exp Hematol       Date:  2008-03       Impact factor: 3.084

5.  TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells.

Authors:  June Li; Daniel P Sejas; Xiaoling Zhang; Yuhui Qiu; Kalpana J Nattamai; Reena Rani; Keaney R Rathbun; Hartmut Geiger; David A Williams; Grover C Bagby; Qishen Pang
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

6.  Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice.

Authors:  Qing-Shuo Zhang; Laura Eaton; Eric R Snyder; Scott Houghtaling; James B Mitchell; Milton Finegold; Carter Van Waes; Markus Grompe
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

7.  Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde.

Authors:  John R Ridpath; Ayumi Nakamura; Keizo Tano; April M Luke; Eiichiro Sonoda; Hiroshi Arakawa; Jean-Marie Buerstedde; David A F Gillespie; Julian E Sale; Mitsuyoshi Yamazoe; Douglas K Bishop; Minoru Takata; Shunichi Takeda; Masami Watanabe; James A Swenberg; Jun Nakamura
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

8.  Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.

Authors:  Sarah Reid; Detlev Schindler; Helmut Hanenberg; Karen Barker; Sandra Hanks; Reinhard Kalb; Kornelia Neveling; Patrick Kelly; Sheila Seal; Marcel Freund; Melanie Wurm; Sat Dev Batish; Francis P Lach; Sevgi Yetgin; Heidemarie Neitzel; Hany Ariffin; Marc Tischkowitz; Christopher G Mathew; Arleen D Auerbach; Nazneen Rahman
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

9.  Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair.

Authors:  Agata Smogorzewska; Shuhei Matsuoka; Patrizia Vinciguerra; E Robert McDonald; Kristen E Hurov; Ji Luo; Bryan A Ballif; Steven P Gygi; Kay Hofmann; Alan D D'Andrea; Stephen J Elledge
Journal:  Cell       Date:  2007-04-05       Impact factor: 41.582

10.  Deubiquitination of FANCD2 is required for DNA crosslink repair.

Authors:  Vibe H Oestergaard; Frederic Langevin; Hendrik J Kuiken; Paul Pace; Wojciech Niedzwiedz; Laura J Simpson; Mioko Ohzeki; Minoru Takata; Julian E Sale; Ketan J Patel
Journal:  Mol Cell       Date:  2007-12-14       Impact factor: 17.970

View more
  77 in total

1.  Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells.

Authors:  Patrizia Vinciguerra; Susana A Godinho; Kalindi Parmar; David Pellman; Alan D D'Andrea
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.

Authors:  Raphael Ceccaldi; Kalindi Parmar; Enguerran Mouly; Marc Delord; Jung Min Kim; Marie Regairaz; Marika Pla; Nadia Vasquez; Qing-Shuo Zhang; Corinne Pondarre; Régis Peffault de Latour; Eliane Gluckman; Marina Cavazzana-Calvo; Thierry Leblanc; Jérôme Larghero; Markus Grompe; Gérard Socié; Alan D D'Andrea; Jean Soulier
Journal:  Cell Stem Cell       Date:  2012-06-07       Impact factor: 24.633

Review 3.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

Authors:  Hyungjin Kim; Alan D D'Andrea
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

4.  Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1.

Authors:  Kalindi Parmar; Jungmin Kim; Stephen M Sykes; Akiko Shimamura; Patricia Stuckert; Kaya Zhu; Abigail Hamilton; Mary Kathryn Deloach; Jeffery L Kutok; Koichi Akashi; D Gary Gilliland; Alan D'andrea
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

Review 5.  Fanconi anemia and the underlying causes of genomic instability.

Authors:  Julie Rageul; Hyungjin Kim
Journal:  Environ Mol Mutagen       Date:  2020-02-06       Impact factor: 3.216

6.  TGF-β Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia.

Authors:  Haojian Zhang; David E Kozono; Kevin W O'Connor; Sofia Vidal-Cardenas; Alix Rousseau; Abigail Hamilton; Lisa Moreau; Emily F Gaudiano; Joel Greenberger; Grover Bagby; Jean Soulier; Markus Grompe; Kalindi Parmar; Alan D D'Andrea
Journal:  Cell Stem Cell       Date:  2016-03-24       Impact factor: 24.633

7.  The Fanconi anemia pathway is required for efficient repair of stress-induced DNA damage in haematopoietic stem cells.

Authors:  Paul Kaschutnig; Ruzhica Bogeska; Dagmar Walter; Amelie Lier; Sina Huntscha; Michael D Milsom
Journal:  Cell Cycle       Date:  2015-07-15       Impact factor: 4.534

8.  Genome-Wide CRISPR Screening Identifies the Tumor Suppressor Candidate OVCA2 As a Determinant of Tolerance to Acetaldehyde.

Authors:  Amin Sobh; Alex Loguinov; Alessia Stornetta; Silvia Balbo; Abderrahmane Tagmount; Luoping Zhang; Chris D Vulpe
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

9.  Loss of Faap20 Causes Hematopoietic Stem and Progenitor Cell Depletion in Mice Under Genotoxic Stress.

Authors:  Tingting Zhang; Andrew F Wilson; Abdullah Mahmood Ali; Satoshi H Namekawa; Paul R Andreassen; Amom Ruhikanta Meetei; Qishen Pang
Journal:  Stem Cells       Date:  2015-05-25       Impact factor: 6.277

10.  Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage.

Authors:  Asmin Tulpule; M William Lensch; Justine D Miller; Karyn Austin; Alan D'Andrea; Thorsten M Schlaeger; Akiko Shimamura; George Q Daley
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.